These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 2955070)
1. Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response. Cozzolino F; Torcia M; Carossino AM; Giordani R; Selli C; Talini G; Reali E; Novelli A; Pistoia V; Ferrarini M J Exp Med; 1987 Aug; 166(2):303-18. PubMed ID: 2955070 [TBL] [Abstract][Full Text] [Related]
2. Presence of activated T-cells with a T8+ M1+ Leu 7+ surface phenotype in invaded lymph nodes from patients with solid tumors. Cozzolino F; Torcia M; Castigli E; Selli C; Giordani R; Carossino AM; Squadrelli M; Cagnoni M; Pistoia V; Ferrarini M J Natl Cancer Inst; 1986 Sep; 77(3):637-41. PubMed ID: 3091897 [TBL] [Abstract][Full Text] [Related]
3. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479 [TBL] [Abstract][Full Text] [Related]
4. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression. Mukherji B; Nashed AL; Guha A; Ergin MT J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419 [TBL] [Abstract][Full Text] [Related]
5. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes. Uchida A; Klein E J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621 [TBL] [Abstract][Full Text] [Related]
6. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells. Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523 [TBL] [Abstract][Full Text] [Related]
7. Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cells. Nakashima M; Janiszewska M; Steplewski Z; Watanabe T; Schuchter L; Koprowski H Hybridoma; 1994 Jun; 13(3):241-6. PubMed ID: 7927369 [TBL] [Abstract][Full Text] [Related]
8. Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer. Mukherji B; Guha A; Loomis R; Ergin MT J Immunol; 1987 Mar; 138(6):1987-91. PubMed ID: 2950174 [TBL] [Abstract][Full Text] [Related]
9. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. Itoh K; Platsoucas CD; Balch CM J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710 [TBL] [Abstract][Full Text] [Related]
10. Immunologic assessment determined by response to IL-2 and immunophenotyping of tumor-infiltrating lymphocytes, of invaded and non invaded lymph nodes and of peripheral blood lymphocytes from twenty-one patients with primary laryngeal cancer. Mantovani G; Maccio A; Zucca MV; Serra MC; Proto E; Locci F; Arangino V; Manduco D; Sulis G; Puxeddu P J Biol Regul Homeost Agents; 1989; 3(1):25-34. PubMed ID: 2786668 [TBL] [Abstract][Full Text] [Related]
11. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer. Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080 [TBL] [Abstract][Full Text] [Related]
13. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors. Miescher S; Whiteside TL; Moretta L; von Fliedner V J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380 [TBL] [Abstract][Full Text] [Related]
14. Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1. Vose BM Arch Geschwulstforsch; 1981; 51(4):317-26. PubMed ID: 6459065 [TBL] [Abstract][Full Text] [Related]
15. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors. Heo DS; Whiteside TL; Kanbour A; Herberman RB J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766 [TBL] [Abstract][Full Text] [Related]
16. Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Fossati G; Taramelli D; Balsari A; Bogdanovich G; Andreola S; Parmiani G Int J Cancer; 1984 May; 33(5):591-7. PubMed ID: 6233227 [TBL] [Abstract][Full Text] [Related]
17. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. I. Proliferation of two distinct T-cell subsets. Uchida A; Moore M; Klein E Int J Cancer; 1987 Aug; 40(2):165-70. PubMed ID: 2956198 [TBL] [Abstract][Full Text] [Related]
18. Functional characterization of T lymphocytes propagated from human lung carcinomas. Kurnick JT; Kradin RL; Blumberg R; Schneeberger EE; Boyle LA Clin Immunol Immunopathol; 1986 Mar; 38(3):367-80. PubMed ID: 3080265 [TBL] [Abstract][Full Text] [Related]
19. Distribution of antigen specific memory T cells in lymph nodes after immunization at peripheral or mucosal sites. Premier RR; Jacobs HJ; Brandon MR; Meeusen EN Immunol Cell Biol; 1996 Jun; 74(3):265-73. PubMed ID: 8799727 [TBL] [Abstract][Full Text] [Related]
20. Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction. Nussenzweig MC; Steinman RM J Exp Med; 1980 May; 151(5):1196-212. PubMed ID: 6445399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]